Name:
fluoxymesterone (9-fluoro-17-alpha-methyl-11-beta,17-beta-dihydroxyandrost-4-en-3-one)
Type:
Androgenic steroid
AKA:
Anadroid-F, Halotestin, Ora-Testryl
fluoxymesterone (9-fluoro-17-alpha-methyl-11-beta,17-beta-dihydroxyandrost-4-en-3-one) image
Synthetic substance, no natural derivative
IUPAC Logo
fluoxymesterone (9-fluoro-17-alpha-methyl-11-beta,17-beta-dihydroxyandrost-4-en-3-one) image
Fluoxymesterone, developed in the 1960s by Upjohn, is a potent anabolic steroid with strong androgenic properties. It has been used medically to treat hormone deficiencies and certain cancers. Due to its strong effects, it has been widely abused in sports and bodybuilding, leading to its control as a performance-enhancing drug.
Synthetic Substances Image
Fluoxymesterone, an anabolic steroid, enhances muscle mass and strength. As an upper, it boosts physical performance and can cause mood swings. Short-term effects include increased strength and muscle mass, while long-term use can lead to cardiovascular problems, liver damage, and hormonal imbalances. Overdose risks include severe health issues. Safe use requires careful medical supervision. Recent research focuses on its effectiveness and potential for serious side effects.
N/A
Fluoxymesterone, an anabolic steroid, affects brain regions related to mood and aggression. Immediate effects include increased aggression and mood swings, with long-term use resulting in cognitive decline and psychological issues. Research highlights its impact on mental health, hormonal balance, and overall safety.
N/A
Fluoxymesterone, a potent anabolic steroid, is used to enhance muscle growth and improve athletic performance. Its cultural significance is linked to its impact on bodybuilding and sports, as well as the controversies surrounding steroid use. Fluoxymesterone reflects ongoing discussions about performance enhancement, including health risks, ethical considerations, and regulatory challenges. Its role in the cultural narrative is one of performance enhancement and the complex issues associated with anabolic steroid use.
N/A